With 1 out of every 4 dogs getting cancer, and with 65 million dogs in the US, there are a lot of dogs with cancer. An estimated 6 million dogs and nearly 6 million cats will be diagnosed with cancer this year. According to The Veterinary Cancer Society, cancer is the leading cause of death in 47% of dogs and 32% of cats.
We found a way to win the battle! We have a way that kills cancer cells and gives HOPE!
We have a new treatment that effectively kills the cancer cells in dogs and with a low cost. The treatment is called Canine Infusion Therapy. It is based on a treatment that is patented in Australia, China and Japan, called “Methods of metabolic targeting cancer cells using chemo and immunotherapy for treating cancer (MMT).” MMT treatment is based on the well-established science that cancer cells need certain nutrients for energy more then ordinary cells do. This is especially true for the so called “cancer stem cells”, which are the only types of cancer cells that can metastasize. The cancer stem cells are highly resistant to conventional chemotherapy because they have high levels of multi-drug resistance (MDR) proteins. The MDRs are located on the surface of the cancer stem cells and they require energy from certain nutrients to operate. The treatment weakens the cancer cell and weakens the multi-drug resistance (MDR) proteins within the cancer cells. Multi-Drug Resistance Proteins work as a pump and are in every cancer cell. They are what makes Chemotherapy drugs significantly less effective because as the cancer cell is taking in the chemotherapy drug the cell via the MDR’s is pumping it out. Our treatments weakens the cancer cell to the point that the MDR’s do not pump out the Chemo and we are able to use only 10% of the normal dos of Chemo and because the cancer cells cannot pump out the chemo it works with out any of the normal side effects of Chemo such as nausea, loss of hair and more.
Through our Infusion Therapy, the cancer cells are deprived of the necessary nutrients and even for the short time of our treatment, the MDRs can be disabled so that chemotherapy drugs can get into the cancer stem cells and kill them. That small dose of Chemo drugs, normally 10% of a regular dose, can kill cancer cells during nutrients deprivation even after the cells have developed resistance to the same drugs at a higher dosages.
It is important to distinguish MMT from other cancer treatments that involve “starving” cancer cells. With those methods, the cancer cells are starved but also the heart and brain are starved as well. With MMT, there is a short “time window” created in which the multi-drug resistant proteins don’t work and the small doses of Chemotherapy drugs are effective in killing the cancer stem cells. There are none of the side effects that result from “staving” the brain and the heart, as in other such treatments.
The inventor, and our Chief Science Officer, Tom Tsang has been a cancer researcher in the US for over 30 years. Tom refined the treatment MMT and attempted to bring the treatment to the US, but since it uses ordinary, already FDA approved drugs and non-patentable over the counter (OTC) agents, no one was interested. They did not see it becoming a billion dollar treatment solution. The first person that Tom treated was his mother’s younger sister for breast cancer in 2006. Today, she is living a totally normal life. In 2009, Tom took the treatment to China and today; Tom’s MMT treatment is being used in 25 hospitals in China. The patented version was filed in 2011.
It is the Canine Cancer Centers goal to conduct a study to translate the MMT treatment used on people to a protocol via our Canine Infusion Therapy that will work as effectively with dogs.
Candidates for our recent Study: We are looking for dogs with Osteosarcoma and Hemangiosarcoma. We would like to have some dogs without Metastasis and some with Metastasis in the lungs. Each dog that we take into the study will not pay any money for the treatment. To qualify for the study, they must have a definitive diagnosis of Osteosarcoma or Hemangiosarcoma with supporting documents including: Health History, X-Rays, Ultra Sounds, and Pathology Reports from their veterinarian or vet oncologist. Dogs who have had other cancer treatments will qualify if it has been longer than 60 days. Dog’s cannot be on any other cancer treatments during the test ore certain medicines.
Phase 1: Establish for dogs the proper protocol for this treatment.
The initial phase of the rollout of our Canine Infusion Therapy will involve a study to establish the dosages and number of treatments for dogs. We know it works on people and we just need to fine-tune the frequency and dosage for dogs as compared to humans.
We want to initially do a trial with 20 dogs.
After the trials, we are looking to open our first two Centers. One in the Dallas/Fort Worth area and one in the Cleveland, Ohio area. Approximately 58% of the population of the U.S. can drive to most cities in Ohio in one day. Future possible cities and locations for our Canine Cancer Centers will be Phoenix, West Palm Beach, Southern California, Northern California, Seattle, New England/NYC area, Atlanta, Tampa, and Denver.
It is our plan ,with our Canine Infusion Therapy, to make it affordable for everyone with a target cost for owners of between $3600 to $4000 for the full treatment.
If you are interested in helping to fund our Canine Infusion Therapy please go to our Crowdfunding Page.